MOESM3 of Epigenetic silencing of MEIS2 in prostate cancer recurrence

Nørgaard, Maibritt; Haldrup, Christa; Bjerre, Marianne; Høyer, Søren; Ulhøi, Benedicte; Borre, Michael; Sørensen, Karina

doi:10.6084/m9.figshare.10027754.v1

13148_2019_742_MOESM3_ESM.pdf (325.15 kB)

MOESM3 of Epigenetic silencing of MEIS2 in prostate cancer recurrence

journal contribution

posted on 2019-10-23, 08:27 authored by Maibritt Nørgaard, Christa Haldrup, Marianne Bjerre, Søren Høyer, Benedicte Ulhøi, Michael Borre, Karina Sørensen

Additional file 3: Figure S1. MDS plots of PC and AN samples from the discovery cohort. For the 450K data, the 1000 most variable CpG sites were used, whereas the 150 most variable genes were used for the RNAseq data.

Funding

Kræftens Bekæmpelse

History

Usage metrics

Keywords

Prostate cancer DNA methylation RNA expression MEIS2 Epigenetic silencing Biomarker Prognosis

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM3 of Epigenetic silencing of MEIS2 in prostate cancer recurrence

Funding

Kræftens Bekæmpelse

History

Usage metrics

Categories

Keywords

Licence

Exports